His bundle pacing therapy for patients with chronic heart failure: A protocol for meta-analysis based on prospective

Yongzheng Zhang1, Mingwang Ding, Zhihong Pu

  • 1Department of CCU, Gansu Provincial Third Hospital, Lanzhou, China.

Medicine
|March 25, 2021
PubMed

Insights

This meta-analysis will evaluate the clinical effectiveness of His bundle pacing (HBP) for patients with chronic heart failure (CHF). It aims to clarify the benefits of HBP therapy in managing heart failure symptoms and improving patient outcomes.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Existing studies on His bundle pacing (HBP) for chronic heart failure (CHF) yield inconclusive results.
  • Clinical benefit of HBP in CHF patients requires further clarification for widespread adoption.
  • A systematic review and meta-analysis is needed to consolidate evidence.

Purpose of the Study:

  • To conduct a comprehensive meta-analysis evaluating the efficacy of His bundle pacing (HBP) therapy.
  • To assess the impact of HBP on chronic heart failure (CHF) patients.
  • To provide a definitive conclusion on HBP's role in CHF management.

Main Methods:

  • Extensive literature search across major databases (PubMed, EMBASE, Cochrane, Web of Science, Chinese databases) up to November 2020.
  • Utilizing STATA 13.0 for robust data synthesis and statistical meta-analysis.
  • Inclusion of studies reporting on HBP therapy for chronic heart failure.

Main Results:

  • Analysis of key outcome measures including QRS duration and left ventricular ejection fraction.
  • Evaluation of functional status using New York Heart Association (NYHA) classification.
  • Assessment of cardiac structure and function, including ventricular diameters and regurgitation severity, alongside BNP levels.

Conclusions:

  • This meta-analysis will synthesize current evidence on His bundle pacing for chronic heart failure.
  • The findings will aim to resolve uncertainties regarding the clinical utility of HBP in CHF.
  • The study will provide evidence-based recommendations for clinicians considering HBP therapy.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
94
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
548
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
75
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
225
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
170
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
135